Search Results - "Philotheou, A."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial by Bartley, P. C., Bogoev, M., Larsen, J., Philotheou, A.

    Published in Diabetic medicine (01-04-2008)
    “…Aims  This 24‐month, multi‐national, open‐label, parallel group trial investigated the long‐term efficacy and safety of insulin detemir and Neutral Protamine…”
    Get full text
    Journal Article
  2. 2

    Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy by Pieber, T. R., Treichel, H-C., Hompesch, B., Philotheou, A., Mordhorst, L., Gall, M-A., Robertson, L. I.

    Published in Diabetic medicine (01-06-2007)
    “…Aims  To compare glycaemic control and risk of hypoglycaemia of twice‐daily insulin detemir with once‐daily insulin glargine in subjects with Type 1 diabetes…”
    Get full text
    Journal Article
  3. 3

    Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes by Kølendorf, K., Ross, G. P., Pavlic-Renar, I., Perriello, G., Philotheou, A., Jendle, J., Gall, M-A., Heller, S. R.

    Published in Diabetic medicine (01-07-2006)
    “…Aims  Hypoglycaemia remains a major barrier preventing optimal glycaemic control in Type 1 diabetes due to the limitations of conventional insulin…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Biphasic insulin aspart vs. human insulin in adolescents with type 1 diabetes on multiple daily insulin injections by Mortensen, Henrik, Kocova, Mirjana, Teng, Lot Yin, Keiding, Jens, Bruckner, Iona, Philotheou, Areti

    Published in Pediatric diabetes (01-02-2006)
    “…:  The aim was to compare clinical efficacy and safety of two treatment regimens: biphasic insulin aspart (BIAsp) injected at all three meals plus neutral…”
    Get full text
    Journal Article